These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 18772725

  • 1. Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected.
    Schmidt CM, Knief A, Lagosch AK, Deuster D, am Zehnhoff-Dinnesen A.
    Ear Hear; 2008 Dec; 29(6):830-7. PubMed ID: 18772725
    [Abstract] [Full Text] [Related]

  • 2. Progressive hearing loss after completion of cisplatin chemotherapy is common and more pronounced in children without spontaneous otoacoustic emissions before chemotherapy.
    Weissenstein A, Deuster D, Knief A, Zehnhoff-Dinnesen AA, Schmidt CM.
    Int J Pediatr Otorhinolaryngol; 2012 Jan; 76(1):131-6. PubMed ID: 22104469
    [Abstract] [Full Text] [Related]

  • 3. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.
    Dhooge I, Dhooge C, Geukens S, De Clerck B, De Vel E, Vinck BM.
    Int J Audiol; 2006 Jun; 45(6):337-43. PubMed ID: 16777780
    [Abstract] [Full Text] [Related]

  • 4. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM, Phillips DS, Fausti SA, Gordon JS, Helt WJ, Wilmington D, Bratt GW, Konrad-Martin D.
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [Abstract] [Full Text] [Related]

  • 5. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
    Knight KR, Kraemer DF, Winter C, Neuwelt EA.
    J Clin Oncol; 2007 Apr 01; 25(10):1190-5. PubMed ID: 17401008
    [Abstract] [Full Text] [Related]

  • 6. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development.
    Knight KR, Kraemer DF, Neuwelt EA.
    J Clin Oncol; 2005 Dec 01; 23(34):8588-96. PubMed ID: 16314621
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Distortion product otoacoustic emissions test is useful in children undergoing cisplatin treatment.
    Toral-Martiñón R, Shkurovich-Bialik P, Collado-Corona MA, Mora-Magaña I, Goldgrub-Listopad S, Shkurovich-Zaslavsky M.
    Arch Med Res; 2003 Dec 01; 34(3):205-8. PubMed ID: 14567400
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Effects of Cisplatin on Auditory Function in Children with cancer. Otoacoustic Emission Evaluation].
    Toral-Martiñón R, Poblano A, Collado-Corona MA, González R.
    Gac Med Mex; 2003 Dec 01; 139(6):529-34. PubMed ID: 14723047
    [Abstract] [Full Text] [Related]

  • 15. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue.
    Freilich RJ, Kraus DH, Budnick AS, Bayer LA, Finlay JL.
    Med Pediatr Oncol; 1996 Feb 01; 26(2):95-100. PubMed ID: 8531860
    [Abstract] [Full Text] [Related]

  • 16. Early cisplatin induced ototoxicity profile may predict the need for hearing support in children with medulloblastoma.
    Lafay-Cousin L, Purdy E, Huang A, Cushing SL, Papaioannou V, Nettel-Aguirre A, Bouffet E.
    Pediatr Blood Cancer; 2013 Feb 01; 60(2):287-92. PubMed ID: 23002030
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ototoxic impact of cisplatin in pediatric oncology patients.
    Berg AL, Spitzer JB, Garvin JH.
    Laryngoscope; 1999 Nov 01; 109(11):1806-14. PubMed ID: 10569412
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.